List view / Grid view
A collaborative team of researchers has discovered two molecules that target the melatonin receptor, responsible for regulating the circadian rhythm. This article delves into their study and its therapeutic relevance for the body clock.
The mechanism in the brain connecting chronic pain and depression could lead to treatments for both, according to researchers.
A study has discovered a molecule key in neuronal growth that could be used as a drug target to treat anxiety-related diseases.
Researchers find key molecule in depression and identify new therapeutic targets.
Researchers have identified a tiny hidden pocket on the NMDA receptor that could be targeted to treat strokes and seizures...
Researchers have found that a single dose of cannabidiol in rats with symptoms of depression was highly effective at eliminating symptoms...
Amorsa Therapeutics' CSO, Michael Palfreyman, discusses how the party drug Ketamine can be used to target NMDA receptors and treat depression...
Researchers have made a ground-breaking discovery revealing new molecular information on how the brain regulates depression and anxiety.
18 October 2016 | By Niamh Louise Marriott, Digital Content Producer
Anti-inflammatory drugs, like those used to treat rheumatoid arthritis and psoriasis could in future be used to treat some cases of depression...
18 August 2016 | By Niamh Louise Marriott, Digital Content Producer
Researchers at Imperial College have studied how the psychedelic substance LSD works in the brain and the effect on speech and language, discovering that...
4 August 2016 | By National Institute of Health (NIH)
Scientists have discovered 15 genome sites — the first ever — linked to depression in people of European ancestry. Many of these regions of depression-linked genetic variation turn out to be involved in regulating gene expression and the birth of new neurons in the developing brain...
12 July 2016 | By Victoria White, Digital Content Producer
Using gene therapy, scientists from Northwestern Medicine have identified a target in the brain that could lead to new treatments for depression...
